Berthold Behl

Inhibitors of GlyT1 Affect Glycine Transport via Discrete Binding Sites

Mario Mezler, Wilfried Hornberger, Reinhold Mueller et al. · Molecular Pharmacology · 2008 · 61 citations

Life Sciences, Neuroscience, Pharmacology +15

A new pyrrolyl‐quinoxalinedione series of non‐NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy

Wolfgang Löscher, Holger Lehmann, Berthold Behl et al. · European Journal of Neuroscience · 1999 · 52 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Towards trans-diagnostic mechanisms in psychiatry: Neurobehavioral profile of rats with a loss of function point mutation in the dopamine transporter gene

Valentina Vengeliene, Anton Bespalov, Martin Roßmanith et al. · Disease Models & Mechanisms · 2017 · 37 citations · Full text

Life Sciences, Neuroscience, Psychiatry +17

In search of the mechanisms of ketamine’s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis

Susanna Popp, Berthold Behl, Jaya Julie Joshi et al. · F1000Research · 2016 · 33 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model

Megan E. Breuer, Marcel M. van Gaalen, Wolfgang Wernet et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 31 citations

Medicine, Neuroscience, Pharmacology +16